Products with high commercial potential
DelSiTech’s own drug products for high unmet clinical and commercial needs.
Read more
Technology applicable to a wide range of drug delivery needs
DelSiTech is the leading technology specialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parenteral and local administration of drug products.
The preferred method for controlled delivery of small molecule drugs, including poorly or highly soluble compounds
Small molecules
Controlled release of biologicals and complex biomolecules such as RNA, DNA and carbohydrates
Proteins and macromolecules
Our partners
DelSiTech currently holds technology licensing agreements with Bayer Pharma AG and Solani Therapeutics Ltd and evaluation agreements with several pharma, animal health and biotech companies.
